Recurrent T Lymphoblastic Leukemia/Lymphoma

1 clinical trials · Condition

Record	Firm	Date
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02538926)	University of Washington	2018-07-01

Every clearance here is in the API, with alerts when new ones post.